Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hematopoietic and Lymphatic System Neoplasm 1

Interventions

Carboplatin 126Cisplatin 125Drug Therapy 103Bevacizumab 98Oxaliplatin 97Capecitabine 97Radiotherapy 94Gemcitabine 87Paclitaxel 85tislelizumab 84Cyclophosphamide 82pembrolizumab 77Specimen Handling 77toripalimab 69Injections 63Fluorouracil 62Magnetic Resonance Spectroscopy 61sintilimab 57anlotinib 53130-nm albumin-bound paclitaxel 51Surgical Procedures, Operative 50Docetaxel 49fludarabine 46Pemetrexed 45venetoclax 42Standard of Care 42Leucovorin 42Irinotecan 41lenvatinib 40Biopsy 39

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Interventional × BNT162 Vaccine × Clear all
NCT07390968 2026-02-09

Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

Fred Hutchinson Cancer Center

Phase 2 Not yet recruiting
56 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡